Joel Edward Goldberg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 11 | 2024 | 1205 | 1.300 |
Why?
|
Rectum | 7 | 2023 | 904 | 0.900 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2023 | 224 | 0.790 |
Why?
|
Colectomy | 3 | 2019 | 680 | 0.650 |
Why?
|
Ileum | 2 | 2020 | 565 | 0.590 |
Why?
|
Military Medicine | 1 | 2018 | 176 | 0.560 |
Why?
|
Colorectal Surgery | 4 | 2020 | 128 | 0.550 |
Why?
|
Perineum | 4 | 2024 | 211 | 0.470 |
Why?
|
Anus Neoplasms | 3 | 2024 | 332 | 0.460 |
Why?
|
Digestive System Surgical Procedures | 4 | 2022 | 576 | 0.450 |
Why?
|
Abdomen | 4 | 2019 | 1118 | 0.390 |
Why?
|
Military Personnel | 1 | 2018 | 1133 | 0.350 |
Why?
|
Neoplasm Staging | 13 | 2021 | 11031 | 0.340 |
Why?
|
Proctocolectomy, Restorative | 2 | 2022 | 189 | 0.330 |
Why?
|
Neuroendocrine Tumors | 3 | 2019 | 594 | 0.330 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1956 | 0.320 |
Why?
|
Colorectal Neoplasms | 5 | 2021 | 6773 | 0.310 |
Why?
|
Appendiceal Neoplasms | 2 | 2019 | 146 | 0.300 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3086 | 0.290 |
Why?
|
Hyperthermia, Induced | 2 | 2021 | 403 | 0.290 |
Why?
|
Treatment Refusal | 2 | 2020 | 421 | 0.280 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3154 | 0.280 |
Why?
|
Appendectomy | 2 | 2019 | 401 | 0.270 |
Why?
|
Foreign Bodies | 1 | 2010 | 400 | 0.260 |
Why?
|
Sigmoidoscopy | 2 | 2019 | 156 | 0.250 |
Why?
|
Peritoneal Neoplasms | 2 | 2021 | 665 | 0.240 |
Why?
|
Laparoscopy | 4 | 2018 | 2150 | 0.240 |
Why?
|
Health Services Accessibility | 2 | 2018 | 5135 | 0.230 |
Why?
|
Lymph Nodes | 3 | 2020 | 3476 | 0.230 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2542 | 0.210 |
Why?
|
Ostomy | 1 | 2022 | 27 | 0.210 |
Why?
|
Appendicitis | 2 | 2019 | 645 | 0.210 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2018 | 868 | 0.210 |
Why?
|
Colon | 5 | 2022 | 1772 | 0.210 |
Why?
|
Colonic Pouches | 1 | 2022 | 121 | 0.190 |
Why?
|
Adenocarcinoma | 6 | 2020 | 6364 | 0.190 |
Why?
|
Duodenal Neoplasms | 1 | 2020 | 106 | 0.180 |
Why?
|
Postoperative Complications | 9 | 2024 | 15297 | 0.180 |
Why?
|
Anastomosis, Surgical | 2 | 2019 | 987 | 0.160 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3616 | 0.160 |
Why?
|
Carcinoma, Large Cell | 1 | 2019 | 113 | 0.160 |
Why?
|
Omentum | 1 | 2019 | 170 | 0.160 |
Why?
|
Goals | 1 | 2023 | 707 | 0.160 |
Why?
|
Occult Blood | 1 | 2018 | 176 | 0.150 |
Why?
|
Biology | 1 | 2020 | 295 | 0.150 |
Why?
|
Anal Canal | 2 | 2019 | 376 | 0.150 |
Why?
|
Propensity Score | 3 | 2020 | 1781 | 0.150 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 319 | 0.150 |
Why?
|
Abdominal Abscess | 1 | 2018 | 154 | 0.150 |
Why?
|
Pelvis | 2 | 2024 | 730 | 0.150 |
Why?
|
Databases as Topic | 1 | 2019 | 475 | 0.140 |
Why?
|
Veterans Health | 1 | 2018 | 216 | 0.140 |
Why?
|
Survival Rate | 9 | 2021 | 12788 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.140 |
Why?
|
Databases, Factual | 6 | 2021 | 7730 | 0.140 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 477 | 0.140 |
Why?
|
Retrospective Studies | 21 | 2024 | 77460 | 0.130 |
Why?
|
Markov Chains | 1 | 2019 | 969 | 0.130 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2019 | 507 | 0.130 |
Why?
|
Mesothelioma | 1 | 2021 | 818 | 0.130 |
Why?
|
Colonic Diseases | 1 | 2016 | 202 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4034 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 332 | 0.120 |
Why?
|
Surgical Flaps | 2 | 2024 | 1640 | 0.120 |
Why?
|
Intestinal Obstruction | 1 | 2018 | 423 | 0.120 |
Why?
|
United States | 16 | 2023 | 69872 | 0.120 |
Why?
|
Insurance Claim Review | 1 | 2018 | 720 | 0.120 |
Why?
|
Intestinal Polyposis | 1 | 2013 | 44 | 0.120 |
Why?
|
Humans | 48 | 2024 | 744366 | 0.110 |
Why?
|
Crohn Disease | 2 | 2020 | 2304 | 0.110 |
Why?
|
Middle Aged | 27 | 2020 | 213390 | 0.110 |
Why?
|
Surgical Wound Infection | 2 | 2019 | 1540 | 0.110 |
Why?
|
Laparotomy | 1 | 2015 | 473 | 0.110 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1683 | 0.110 |
Why?
|
Length of Stay | 4 | 2019 | 6311 | 0.100 |
Why?
|
Colonoscopy | 2 | 2017 | 1367 | 0.100 |
Why?
|
Lymphoma | 1 | 2020 | 1877 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2022 | 1911 | 0.090 |
Why?
|
Medically Uninsured | 1 | 2016 | 853 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1487 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1257 | 0.090 |
Why?
|
Incidence | 4 | 2021 | 20952 | 0.090 |
Why?
|
Female | 30 | 2022 | 380193 | 0.090 |
Why?
|
Male | 28 | 2021 | 350115 | 0.090 |
Why?
|
Hospitals, Community | 2 | 2021 | 347 | 0.080 |
Why?
|
Lacerations | 1 | 2010 | 144 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2019 | 1796 | 0.080 |
Why?
|
Tomography, Emission-Computed | 1 | 2010 | 1144 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1968 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2018 | 1900 | 0.070 |
Why?
|
Radiotherapy | 1 | 2013 | 1533 | 0.070 |
Why?
|
Aged | 18 | 2020 | 163288 | 0.070 |
Why?
|
Carcinoid Tumor | 1 | 2008 | 235 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2020 | 63107 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1694 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4253 | 0.070 |
Why?
|
Critical Care | 1 | 2018 | 2647 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29060 | 0.060 |
Why?
|
Computer Simulation | 1 | 2019 | 6194 | 0.060 |
Why?
|
Device Removal | 1 | 2010 | 656 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
Population Surveillance | 1 | 2015 | 2616 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9240 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2016 | 1671 | 0.060 |
Why?
|
Intestine, Small | 2 | 2020 | 1240 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1237 | 0.060 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8642 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5791 | 0.060 |
Why?
|
Palliative Care | 1 | 2018 | 3493 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3208 | 0.050 |
Why?
|
Mass Screening | 1 | 2018 | 5253 | 0.050 |
Why?
|
Microsurgery | 1 | 2008 | 796 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10252 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 2016 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11525 | 0.050 |
Why?
|
Medicare | 2 | 2018 | 6566 | 0.050 |
Why?
|
Anticoagulants | 1 | 2016 | 4600 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39052 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4839 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12356 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 25039 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57776 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2010 | 2645 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5263 | 0.050 |
Why?
|
Fatty Liver | 1 | 2006 | 727 | 0.040 |
Why?
|
Mitomycin | 1 | 2019 | 259 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 7023 | 0.040 |
Why?
|
Age Factors | 3 | 2020 | 18373 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 215 | 0.040 |
Why?
|
Hepatectomy | 1 | 2021 | 550 | 0.040 |
Why?
|
Adult | 12 | 2019 | 214052 | 0.040 |
Why?
|
Fertility | 1 | 2022 | 781 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 12802 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2006 | 812 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3252 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2023 | 4369 | 0.040 |
Why?
|
Drug Therapy | 1 | 2020 | 497 | 0.040 |
Why?
|
Clinical Competence | 2 | 2023 | 4687 | 0.040 |
Why?
|
Patient Preference | 1 | 2023 | 889 | 0.030 |
Why?
|
Neoplasms | 2 | 2016 | 21696 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 692 | 0.030 |
Why?
|
Gastrostomy | 1 | 2018 | 310 | 0.030 |
Why?
|
Hawaii | 1 | 2015 | 105 | 0.030 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2016 | 199 | 0.030 |
Why?
|
Patient Readmission | 2 | 2019 | 3116 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 6234 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12244 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2065 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2902 | 0.030 |
Why?
|
Health Priorities | 1 | 2016 | 380 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2013 | 188 | 0.030 |
Why?
|
DNA Glycosylases | 1 | 2013 | 128 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1787 | 0.030 |
Why?
|
Perioperative Care | 1 | 2019 | 1002 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3480 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3508 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13693 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5077 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2010 | 588 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1768 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2269 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6539 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 53290 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 980 | 0.020 |
Why?
|
Young Adult | 4 | 2016 | 56429 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2494 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10400 | 0.020 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2006 | 87 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5321 | 0.020 |
Why?
|
Radiometry | 1 | 2010 | 800 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3553 | 0.020 |
Why?
|
Patient Discharge | 1 | 2016 | 3318 | 0.010 |
Why?
|
Obesity | 1 | 2006 | 12746 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 85779 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2006 | 640 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 40559 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2006 | 638 | 0.010 |
Why?
|
Intestines | 1 | 2010 | 1924 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13409 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1641 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12952 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 3326 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8319 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5300 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10259 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11126 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 72296 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35134 | 0.010 |
Why?
|
Blood Glucose | 1 | 2006 | 6254 | 0.010 |
Why?
|
Liver | 1 | 2006 | 7475 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13286 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20824 | 0.000 |
Why?
|
Body Mass Index | 1 | 2006 | 12721 | 0.000 |
Why?
|